lipid lowering agent that blocks the initial step in cholesterol synthesis
HMG Coa reductase inhibitor
lipid lower agent which produce a lipid profile of elevated HDL and low LDL, VLDL and cholesterol
HMG Coa reductase inihibitor
lipid lowering agent with side effects of renal failure, rhabdomyolysis, myopathy and hepatic insufficiency
HMG Coa reductase inhibitor
upon the action of HMG Coa reductase, the HMG Coa will be converted to what substance?
Mevalonate
lipid lowering agent that lower absorption of fat soluble substances
Bile acid sequesterant
lipid lowering agent that disrupt the enterohepatic circulation of bile acids by combining with bile constituents and preventing reabsorption from the gut
Bile acid sequesterant
lipid lowering agent that also used to treat hyperthyroidism as an adjunct therapy
Bile acid sequesterant
by inhibiting the enterohepatic circulation, more L-thyroxine will be lost through defecation, thus lowering body thyroxine levels.
lipid lowering agent which produce a lipid profile of elevated HDL, VLD and Triglycerides; and decreases cholesterol and LDL